Beijing Sun-Novo Pharmaceutical Research Co Ltd
SSE:688621
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Zhejiang Zone-King Environmental Sci&Tech Co Ltd
SSE:688701
|
CN |
|
S
|
SFK Construction Holdings Ltd
HKEX:1447
|
HK |
Beijing Sun-Novo Pharmaceutical Research Co Ltd
Research & Development
Beijing Sun-Novo Pharmaceutical Research Co Ltd
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Beijing Sun-Novo Pharmaceutical Research Co Ltd
SSE:688621
|
Research & Development
-¥153.5m
|
CAGR 3-Years
-50%
|
CAGR 5-Years
-53%
|
CAGR 10-Years
N/A
|
|
|
WuXi AppTec Co Ltd
SSE:603259
|
Research & Development
-¥1.1B
|
CAGR 3-Years
12%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
Pharmaron Beijing Co Ltd
SZSE:300759
|
Research & Development
-¥535.2m
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-42%
|
CAGR 10-Years
N/A
|
|
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
Research & Development
-¥853.4m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
|
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
Research & Development
-¥248.3m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-25%
|
|
|
W
|
WuXi XDC Cayman Inc
HKEX:2268
|
Research & Development
-¥147.2m
|
CAGR 3-Years
-67%
|
CAGR 5-Years
-105%
|
CAGR 10-Years
N/A
|
|
Beijing Sun-Novo Pharmaceutical Research Co Ltd
Glance View
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. engages in the research and development of pharmaceutical products. The company is headquartered in Beijing, Beijing and currently employs 873 full-time employees. The company went IPO on 2021-06-21. The firm's main businesses include comprehensive research and development services in generic drug development, consistency evaluation and innovative drug development. Its services mainly include pharmaceutical research, clinical trials and biological analysis. Pharmaceutical research services include raw materials and preparation process research, quality standards and stability research, etc. Clinical trial services include phase I-IV clinical trial research, Bioequivalency (BE) test research. Biological analysis services include the use of mass spectrometry analysis platform, immunoassay platform, cell analysis platform, molecular biology analysis platform for method development, method validation, biological sample detection research, etc. The firm mainly conducts its businesses in the domestic market.
See Also
What is Beijing Sun-Novo Pharmaceutical Research Co Ltd's Research & Development?
Research & Development
-153.5m
CNY
Based on the financial report for Dec 31, 2024, Beijing Sun-Novo Pharmaceutical Research Co Ltd's Research & Development amounts to -153.5m CNY.
What is Beijing Sun-Novo Pharmaceutical Research Co Ltd's Research & Development growth rate?
Research & Development CAGR 5Y
-53%
Over the last year, the Research & Development growth was -45%. The average annual Research & Development growth rates for Beijing Sun-Novo Pharmaceutical Research Co Ltd have been -50% over the past three years , -53% over the past five years .
